1. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
   Franziska Sotzny et al, 2022, Frontiers in Immunology CrossRef
2. Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review
   Arina Lezhnina et al, 2022, BioNanoScience CrossRef
3. Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
   Suzanne D. Vernon et al, 2022, Frontiers in Medicine CrossRef
4. Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors
   Felix S. Seibert et al, 2023, Autoimmunity Reviews CrossRef
5. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
   Otávio Cabral-Marques et al, 2023, Autoimmunity Reviews CrossRef
6. Immunological Related Status of Chronic Fatigue Syndrome
   婕 王, 2018, Advances in Clinical Medicine CrossRef
7. Cytokine Research in Depression: Principles, Challenges, and Open Questions
   Hubertus Himmerich et al, 2019, Frontiers in Psychiatry CrossRef
8. Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
   Lily Chu et al, 2019, Frontiers in Pediatrics CrossRef
9. Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies
   Isabell Nilsson et al, 2020, Frontiers in Medicine CrossRef
10. Higher Prevalence of “Low T3 Syndrome” in Patients With Chronic Fatigue Syndrome: A Case–Control Study
    Begoña Ruiz-Núñez et al, 2018, Frontiers in Endocrinology CrossRef